The launch of OxyContin—one of the most sophisticated and aggressive drug-marketing campaigns the world of medicine has ever seen—was targeted at states without triplicate laws. So, no big push in New York State. But yes to West Virginia. No to Illinois. But yes to Indiana. No to California. But yes to Nevada. No to Texas and Idaho. But yes to Oklahoma and Tennessee—with the result that the opioid epidemic did not hit the entire United States equally.
